HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 749: | Line 749: | ||
|Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | |Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 | ||
|Tracy Tucker, PhD, FCCMG | |Tracy Tucker, PhD, FCCMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 765: | Line 765: | ||
|Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | |Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged | ||
|Tracy Tucker, PhD, FCCMG | |Tracy Tucker, PhD, FCCMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 797: | Line 797: | ||
|Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | |Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified | ||
|Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | |Priyatharsini Nirmalanantham, MD and Shashi Shetty, PhD | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 813: | Line 813: | ||
|Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | ||
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | |Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 829: | Line 829: | ||
|Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | |Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types | ||
|Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | |Elicia Goodale, MD, Medical University of South Carolina Daynna Wolff, PhD, Medical University of South Carolina | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 861: | Line 861: | ||
|Acute Undifferentiated Leukemia | |Acute Undifferentiated Leukemia | ||
|Amelia Nakanishi, MD and Shashi Shetty, PhD | |Amelia Nakanishi, MD and Shashi Shetty, PhD | ||
|Complete | |||
| | | | ||
| | |Check reference format | ||
|- | |- | ||
|CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) | |CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) | ||